ADAM CAREY: Open Payments
NPI 1750081535 · CUMBERLAND, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,139 in 101 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $2,077 · 2025 $2,139
Food & beverage: $2,139
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $509 |
| GlaxoSmithKline, LLC. | 12 | $207 |
| Aimmune Therapeutics, Inc. | 9 | $187 |
| Exact Sciences Corporation | 9 | $181 |
| ABBVIE INC. | 12 | $159 |
| TOLMAR, INC. | 8 | $146 |
| Novo Nordisk Inc | 6 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $102 |
| Amgen Inc. | 4 | $100 |
| Lilly USA, LLC | 3 | $85 |
Products named: AIRSUPRA, Cologuard Collection Kit, BREZTRI, TRELEGY ELLIPTA, JATENZO, FARXIGA, ZENPEP, QULIPTA.
Industry payments across RI — which companies pay providers there.
